BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 121 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,224,101 | -64.9% | 106,629 | -61.5% | 0.06% | -68.8% |
| Q3 2022 | $3,486,000 | -9.5% | 276,629 | -24.1% | 0.20% | -9.8% |
| Q2 2022 | $3,854,000 | +25.4% | 364,252 | -11.7% | 0.22% | +100.0% |
| Q4 2020 | $3,073,000 | +6.7% | 412,419 | -50.8% | 0.11% | -24.8% |
| Q3 2020 | $2,881,000 | +38.5% | 838,719 | +92.1% | 0.15% | -25.5% |
| Q2 2020 | $2,080,000 | -72.3% | 436,500 | -80.0% | 0.20% | -69.8% |
| Q4 2019 | $7,521,000 | +873.0% | 2,179,950 | +2053.1% | 0.66% | +306.1% |
| Q3 2018 | $773,000 | -1.7% | 101,245 | -32.5% | 0.16% | -29.1% |
| Q3 2017 | $786,000 | +41.4% | 150,000 | +50.0% | 0.23% | +4.1% |
| Q2 2017 | $556,000 | – | 100,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |